Enrolling by invitationNCT05308927
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
Studying Noonan syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novo Nordisk A/S
- Principal Investigator
- Clinical Transparency dept. 2834Novo Nordisk A/S
- Intervention
- Norditropin(drug)
- Enrollment
- 221 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2028
Study locations (3)
- Centre Hospitalier Universitaire D'Angers-2, Angers, France
- Ap-Hp-Hopital de Bicetre-2, Le Kremlin-Bicêtre, France
- Hopital Des Enfants-2, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05308927 on ClinicalTrials.govOther trials for Noonan syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07464821National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and GenotypeIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT06555237MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathiesMedical University of Warsaw
- RECRUITINGNCT05202210Constitution of a Biological Collection to Study the Pathophysiology in Noonan SyndromeUniversity Hospital, Toulouse